Arzeda, founded in 2009, is a pioneering company in the fields of AI, Biotechnology, and Manufacturing. It focuses on developing innovative proteins and enzymes that aim to revolutionize the production of sustainable molecules. As The Protein Design Company™, Arzeda aligns its offerings with performance, cost-effectiveness, and sustainability.
The company has strategically partnered with Fortune 500 companies to expand its influence and utility across industries such as polymers, pharmaceuticals, and industrial chemicals. Through these collaborations, Arzeda has curated an extensive portfolio of specialty chemical products for advanced applications.
Headquartered in the United States, Arzeda recently secured a $7.80M grant from the National Science Foundation on September 1, 2025, emphasizing its credibility and growth potential within synthetic biology. These developments position Arzeda as a compelling opportunity for investors interested in leveraging cutting-edge biotechnological solutions for sustainable production.